Notebook

LEAVING HOWARD HUGHES After serving as the president of the Howard Hughes Medical Institute since 1987, Purnell W. Choppin has announced his resignation. "While my enthusiasm for the position I have been privileged to hold and my dedication to the Institute remain as intense as ever, I believe that it will be time for someone to take up the reins and lead HHMI into the new millennium," Choppin wrote in a letter to the institute's staff. He will remain in the position through 1999. Under Choppin


Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

LEAVING HOWARD HUGHES After serving as the president of the Howard Hughes Medical Institute since 1987, Purnell W. Choppin has announced his resignation. "While my enthusiasm for the position I have been privileged to hold and my dedication to the Institute remain as intense as ever, I believe that it will be time for someone to take up the reins and lead HHMI into the new millennium," Choppin wrote in a letter to the institute's staff. He will remain in the position through 1999. Under Choppin's tenure, the institute's budget grew from $77 million to $556 million. Choppin also oversaw the construction of the Institute's campus headquarters and conference center in Chevy Chase, Md. Choppin came to HHMI in 1985 as vice president and chief scientific officer from Rockefeller University, where he was Leon Hess Professor of Virology, vice president for academic programs, and dean of graduate studies. He headed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide